Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study it to learn the effects (good or bad) that rosiglitazone has on
patients and their prostate cancer. This study is going to look at what effects rosiglitazone
has on prostate specific antigen (PSA) levels.